Multi-system neurological disease is common in patients with OPA1 mutations

Patrick Yu‐Wai‐Man(Royal Victoria Infirmary), Patrick F. Chinnery(Wellcome Centre for Mitochondrial Research), Gráinne S. Gorman(Wellcome Centre for Mitochondrial Research), Marcela Votruba(University Hospital of Wales), Baljean Dhillon(University of Edinburgh), Philip Duffey(The Neurosciences Foundation), Pascal Reynier(Centre National de la Recherche Scientifique), Laurence A. Bindoff(Haukeland University Hospital), Charles Marques Lourenço(Universidade de São Paulo), Rita Horváth(University of Cambridge), Leonardo Caporali(Istituto delle Scienze Neurologiche di Bologna), Michael W. Clarke(The University of Western Australia), Wilson Marques(Universidade de São Paulo), Gavin Hudson(Wellcome Centre for Mitochondrial Research), Massimo Zeviani(IRCCS Materno Infantile Burlo Garofolo), Douglass M. Turnbull(Royal Victoria Infirmary), Costanza Lamperti(West Virginia University), Robert McFarland(Wellcome Centre for Mitochondrial Research), Maria Lucia Valentino(Istituto delle Scienze Neurologiche di Bologna), Roger G. Whittaker(Wellcome Centre for Mitochondrial Research), Chantal Tallaksen(Oslo University Hospital), Philip G. Griffiths(Royal Victoria Infirmary), Patrizia Amati‐Bonneau(Inserm), Valério Carelli(Istituto delle Scienze Neurologiche di Bologna), Dominique Bonneau(Centre Hospitalier Universitaire d'Angers), Mark R. Baker(Royal Victoria Infirmary), O. Musumeci(University of Messina), Joanna D. Stewart(Wellcome Centre for Mitochondrial Research), James Miller(Royal Victoria Infirmary), António Toscano(University of Messina), Guy Lenaers(Centre National de la Recherche Scientifique), Birgit Czermin(Medical Genetics Center), Alan F. Wright(University of Exeter), Margaret Jackson(Royal Victoria Infirmary), Robert W. Taylor(Newcastle upon Tyne Hospitals NHS Foundation Trust), Michaela Auer‐Grumbach(Vienna General Hospital)
Brain
February 15, 2010
Cited by 446


Related Papers